The participants including male and female patients with terminal stage cancer, primary or metastasis causes, admission for supportive treatment, age over 18 years, religious, marital status, length of stay, medical expense under any health coverage, consultant and palliative care team with details of prescription (aggressive treatment, non-resuscitation with and without inotropes), were retrieved from Hospital Informatics System, Cancer center, Chulabhorn Hospital during October 2018 thru March
Conditions
Interventions
Advanced cancer patients including endotracheal intubation, cardiac resuscitation and inotropes,Advanced cancer patients not requiring endotracheal intubation, cardiac resuscitation except for inotro
Terminal stage cancer patients with Aggressive treatment (AT),Terminal stage cancer patients with Non resuscitation with inotropes (NRw),Terminal stage cancer patients with Non resuscitation and witho
Sponsors
Chulabhorn Royal Academy
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: This study recruited participants with advanced cancer patients from Hospital Informatics System consisting of male and female aged over 18 years, religious, marital status, length of stay, and medical expense under any health coverage.
Exclusion criteria
Exclusion criteria: Participants without diagnosis of not advanced cancer stage and no admission for supportive treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| less medical expense 7 days prior to admission One-way ANOVA | — |
Secondary
| Measure | Time frame |
|---|---|
| an explicit guideline for end of life care date of death quality of death | — |
Countries
Thailand
Contacts
Public ContactRuechuta Molek
Chulabhorn Royal Academy
Outcome results
None listed